Novartis India has entered into a Supply & Distribution Agreement with Themis Medicare on August 16, 2013. As per agreement, Themis has agreed to manufacture and supply and Novartis has agreed long term exclusive purchase from Themis Diclofenac Sodium 75 mg per ml Injection as finished dosage pharmaceutical form on certain commercial terms and conditions for Indian market.
http://www.epicresearch.co/0731-664-2300
0 comments:
Post a Comment